Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03872843 · ClinicalTrials.gov registry record · Phase 4
Opioid Free Management After Ureteroscopy
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT03872843 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 22 participants.
The verdict
NCT03872843, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare how well two medications work to control post-operative pain.
Interventions
- DRUG Norco 5milligram-325milligram Tablet
- DRUG Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATED
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-09-19 |
| Est. Completion | 2020-02-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03872843
The ClinicalTrials.gov registry entry for NCT03872843 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Norco 5milligram-325milligram Tablet is the first listed.
NCT03872843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03872843 about?
NCT03872843 is a clinical study titled "Opioid Free Management After Ureteroscopy". The purpose of this research study is to compare how well two medications work to control post-operative pain.
What is the current status of trial NCT03872843?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2019-09-19. Estimated completion is 2020-02-26.
What interventions are being tested in trial NCT03872843?
The interventions under investigation include: Norco 5milligram-325milligram Tablet (DRUG), Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATED (DRUG).
Who is sponsoring clinical trial NCT03872843?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.